欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4595/002
药品名称Dasatanib Viatris 50 mg film-coated tablet
活性成分
    • Dasatinib 50.0 mg
剂型Film-coated tablet
上市许可持有人Viatris Limited Damastown Industrial Park, Mulhuddart 15 Dublin Ireland
参考成员国 - 产品名称Netherlands (NL)
Dasatinib Viatris 50 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Dasatinib Mylan 50 mg filmomhulde tabletten
    • Luxembourg (LU)
      Desatinib Mylan, 50 mg, Comprimé pelliculé
    • Iceland (IS)
      Dasatinib Mylan 50 mg Filmuhúðuð tafla
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Dasatinib Genthon
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Dasatanib Mylan
    • Latvia (LV)
      Dasatinib Viatris 50 mg apvalkotās tabletes
    • Lithuania (LT)
      Dasatinib Mylan 50 mg plėvele dengtos tabletės
    • Estonia (EE)
      DASATINIB MYLAN
    • Hungary (HU)
      DASATINIB MYLAN 50 mg filmtabletta
    • Czechia (CZ)
      Dasatinib Genthon
许可日期2019/08/07
最近更新日期2025/02/03
药物ATC编码
    • L01EA02 dasatinib
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase